NASDAQ · MRM

MEDIROM Healthcare Technologies Inc.. American

$0.99 +$0.00 (+0.41%) 1D Market open

Key Metrics

$7.79M
Market cap
P/E · TTM
Revenue · TTM
Net income
EPS · TTM
Dividend yield
Free cash flow
Beta · 1Y 0.19
EBITDA · TTM
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • May 22
    The stock moved +30.3% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 22
  • May 14
    From its Jan 30 high, the share price fell 39%.

    Peak close $1.48 on Jan 30; trough close $0.91 on May 14. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -39%
  • Apr 15
    The stock moved +13.5% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Apr 15

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$7.79M
Enterprise value$1.23B
Shares outstanding7.9M
52-wk range$0.90 – $4.45
Avg volume · 20D442.6K
Net cash −$1.22B
Book value / share$30.73
ExchangeNASDAQ
About MEDIROM Healthcare Technologies Inc.. American
IPO dateDec 29, 2020
Employees1051

MEDIROM Healthcare Technologies Inc provides health services. The company is a franchiser and operator of healthcare salons and operates in segments namely Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty Segment.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S
P/FCF
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross
Operating
Net
FCF
ROE / ROIC — · —

Financial Health

Current ratio0.24
Quick ratio0.21
Debt / equity5.55
Debt / EBITDA
Net cash −$1.22B
Working capital−$3.77B

Cash Flow · TTM

Operating CF
Capex
Free cash flow
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

5 / 9
Middling fundamentals · 5 of 9 signals passing

Altman Z-Score

Insufficient balance-sheet inputs

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2025-06-30 · computed by TickerWolf from SEC filings